Contact
Please use this form to send email to PR contact of this press release:
Immutep Presents Positive Interim Data From Phase II TACTI-002 Trial at SITC
TO:
Please use this form to send email to PR contact of this press release:
Immutep Presents Positive Interim Data From Phase II TACTI-002 Trial at SITC
TO: